Close Menu

NEW YORK (GenomeWeb) – BioDirection said this week that its Tbit System for traumatic brain injury has received breakthrough device designation from the US Food and Drug Administration. The technology detects and measures protein biomarkers released from the brain immediately after head trauma and is meant to predict positive computerized tomography scans after such injuries.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A tissue sample from the 1960s harbors a near-complete sample of HIV, IFLScience reports.

A new bill would reshape the US National Science Foundation to include a focus on technological development, according to Science.

The Food and Drug Administration's decision to halt a SARS-CoV-2 study has drawn criticism, according to Stat News.

In Genome Biology this week: features affecting gut microbiome and parasite patterns, cellular interactions in lung tumor microenvironment, and more.